Dutch scientists, who looked at the issue of magnesium consumption and the risk of colorectal cancer, invited 758 sick and 709 healthy people to their work. Magnesium was found to be significant reduced the risk of adenomas (a precursor to cancer) in people who have a BMI of 25 or over, or who are over 55 years of age, or who already have advanced adenomas. For pancreatic cancer, the researchers used data from EPIC Cohort, a European study involving 334 women and 999 men. The mean follow-up was 142 years. The analyzes here showed that each additional 100 mg of magnesium daily reduces the risk of developing pancreatic cancer by 21% in people with a BMI of 25 or more. Moreover, these results are in line with the results of the UK study, only on men. It turned out that the men who take 423 mg of magnesium daily (highest dose) are 33% less likely to have pancreatic cancer than men who take 281 mg / day (lowest dose).
source: ScienceNews.pl